Diseases of the Nervous System, Phase II

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Volunteers
Health Professionals

What is the purpose of this trial?

The purpose of this study is to assess the efficacy, safety, and tolerability profile of CVL-865 as adjunctive treatment in participants with drug-resistant focal onset seizures.

Trial with
Cerevel Therapeutics, LLC
Ages
18 years - 75 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Margaret Gopaul

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Aline Herlopian, MD
Assistant Professor; Affiliated Faculty , Yale Institute for Global Health

Sub-Investigator

Lawrence Hirsch, MD

Last Updated
07/10/2023
Study HIC
#2000027109